Antigens of Tumours Induced by Naturally Occurring Murine Sarcoma Virus (MSV-FBJ): II. Detection of Cell-Surface Antigens by Indirect Membrane Immunofluorescence by Jones, D. B. & Moore, M.
Br J. Cancer (1974) 29, 158
ANTIGENS OF TUMOURS INDUCED BY NATURALLY OCCURRING
MURINE SARCOMA VIRUS (MSV-FBJ)
II. DETECTION OF CELL-SURFACE ANTIGENS BY INDIRECT
MEMBRANE IMMUNOFLUORESCENCE
D. B. JONES* AND M. MOOREt
Frokn the Charles Salt Research Centre, Robert Jones and Agnes Hunt Orthopaedic Hospital,
Oswestry, Shropshire, SY1O 7AG, England
Received 1 November 1973. Acceptecl 21 November 197:3
Summary.-Cell surface antigens expressed by cells transformed in vivo by FBJ
virus, a wild type murine sarcoma virus (MSV) complex derived from a spontane-
ously arising sarcoma in a CF1 mouse, have been studied by indirect membrane
immunofluorescence (MIF). Using mouse antisera raised by immunization of
syngeneic CBA mice with transplanted FBJ sarcomata an antigen common to all
FBJ tumours was detected which was also present on Gross (G) antigen positive
tissues, viz. leukaemic and preleukaemic AKR lymphoid cells, but absent from the
tissues of mice of G negative strains. Failure to demonstrate antigenic cross-
reactivity in reciprocal MIF tests using FBJ immune sera and antisera to MSV-H
(Harvey), an MSV isolate of Friend-Moloney-Rauscher (FMR) sub-group specificity,
established the virus type-specificity of antigens expressed by sarcoma cells trans-
formed by the respective MSV.
The presence of a cellular antigen with G specificity on FBJ sarcoma cells was
confirmed in tests with aged exbreeding C57B1 antisera containing naturally occur-
ring G antibody lacking significant virus neutralizing activity. However, evidence
for a " sarcoma-non-leukaemia " antigen on cells transformed by MSV-FBJ was not
obtained since absorption studies failed to reveal any specificity on FBJ sarcoma
cells which was not also present on AKR leukaemic tissues.
It is suggested that the major humoral component of the immune response to
FBJ sarcoma cells is evoked against antigens specified by the associated non-
pathogenic leukaemia virus (MLV-FBJ) and the relationship of antigens demon-
strated by MIF to those detected previously by complement fixation (CF) and tumour
rejection tests is discussed.
FBJ VIRUS, a murine sarcoma virus 1973). Immunological studies have estab-
(MSV-FBJ) isolated in association with a lished that the FBJ viruses possess the
non-pathogenic murine leukaemia virus group-specific (gs) antigens of murine
(MLV-FBJ) from a spontaneously arising leukaemia virus (MLV) and the type
sarcoma in a CFI mouse (Finkel, Biskis specificity of the Gross (G) or wild type
and Jinkins, 1966), bears a close morpho- subgroup of murine oncorna-viruses,
logical and biochemical relationship to by contrast with other MSV isolates
other members of the RNA murine leu- (e.g. MSVT-Harvey) of Friend-Moloney-
kaemia-sarcoma virus complex (Biskis and Rauscher (FMR) subgroup specificity
Finkel, 1969; Rhim et al., 1969; Levy et al., (Kelloff et al., 1969; Jones and Moore,
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1974). In addition the antigenicity of
MSV-FBJ transformed cells has been
studied by techniques designed to detect
cell-surface antigens. In a previous paper
it was shown that FBJ sarcomata were
immunogenic in syngeneic hosts (Jones
and Moore, 1973). The purpose of the
present complementary study was to
characterize the type-specificity of cell-
surface antigens expressed by FBJ cells
using the indirect membrane immuno-
fluorescence (MIF) technique on viable
cell suspensions derived from FBJ sarco-
mata, known Gross (G) antigen positive
tissues and on cells transformed by
MSV-H.
MATERIALS AND METHODS
Animals.-Syngeneic CBA(H), AKR and
C57B1 mice and AS rats were obtained from
colonies maintained in this laboratory by
strict brother/sister mating. Animals which
had received virus or virus infected tissues
were maintained in isolation; in particular,
care was taken to avoid cross-contamination
of MSV strains.
Tumours.-FBJ sarcomata were induced
in CBA(H) mice by neonatal injection of
MSV-FBJ (Price, Moore and Jones, 1972) and
transplanted in syngeneic CBA(H) mice.
Gross antigen positive tissue was obtained
from AS strain rat lymphomata induced by
neonatal injection of Gross Passage A Virus
(American Type CultureCollection, Maryland,
U.S.A.-Batch No. VR 589 2D), or from
leukaemic or pre-leukaemic AKR mice.
MSV-H induced sarcomata developed in
CBA(H) mice following neonatal injection
into the thigh muscle of cell free preparations
of MSV-H (Harvey and East, 1971) gener-
ously supplied by Dr J. J. Harvey (MRC
Clinical Research Centre, Northwick Park,
Harrow, Middlesex), andwere passaged in pre-
irradiated (400 rad) syngeneic mice (Jones
and Moore, 1974).
Transplantable radiation induced murine
sarcomata of putatively non-viral origin were
obtained from Dr J. Loutit (MRC Radio-
biology Unit, Harwell, Didcot, Berkshire).
A transplantable sarcoma (P8) in AS strain
rats was induced in this laboratory by chronic
administration of radioactive phosphorus
(32p)
Cell suspensions.-Suspensions of GLV
and MSV-H induced tumours and normal
spleens were prepared by finely mincing fresh
tissue with scissors in Eagle's minimal essen-
tial medium (MEM) and passage through fine
gauze (Gauge 45, Joseph Nichols Ltd,
Cheapside, Birmingham) into sterile centri-
fuge tubes.
FBJ cell preparations were obtained by
enzymatic digestion of fresh tumour at 37°C
with constant stirring in 0.25% trypsin
(Biocult Ltd, Paisley, Scotland) or 0 25%
collagenase (Sigma Chemical Co., Kingston
upon Thames, Surrey) in Hank's Balanced
Salt Solution. Collagenase was preferable
for most MSV-FBJ induced lesions as it
liberated cells with greater facility from the
matrix and consequently reduced the period
of exposure to enzyme. In general, incuba-
tion times did not exceed 20 min.
Antisera.-Serum samples were obtained
aseptically from the retro-orbital sinus 10
days post-immunization with bilateral sub-
cutaneous implants of irradiated isografts of
FBJ sarcomata, or following excision of
developing FBJ tumours (Jones and Moore,
1973). Additional samples were obtained by
exsanguination of mice bearing FBJ sarcoma
transplants.
Antisera reactive with the cell surface
antigens of FBJ sarcomata were produced by
4 i.p. inoculations of x-irradiated (15,000 rad)
sarcoma cells at a minimum cell dose of
2 x 106 cells per immunization.
Antisera reactive with the cell surface
antigens of MSV-H were obtained either
following intraperitoneal injection of onco-
geneic MSV-H or after repeated injection of
2 x 106 x-irradiated (15,000rad) MSV-H
induced sarcoma cells.
Antisera containing naturally occurring
antibody reactive with tissues of Gross (G)
antigen specificity were obtained from aged
exbreeding female C57B1 mice. These sera
were screened for activity against G antigen
bearing cells (e.g. AKR lymphoid cells) prior
to useinmembrane immunofluorescence tests.
Heterologous antiserum with reactivity
against Gross virus-associated antigens was
obtained from syngeneic AS rats bearing
transplants of GLV-induced lymphomata.
Antiserum absorption.-Cell suspensions
for absorption were obtained by enzymatic
digestion or mechanical dissociation of tissue
as described above, washed twice in PBS and
their viability estimated by Trypan BlueD. B. JONES AND M. MOORE
exclusion. For absorption of 1 ml of the
respective antisera, cells were adjusted to the
requisite concentration, packed by centrifuga-
tion, resuspended inthe appropriate volume of
antiserum andincubatedovernight at40Cw,ith
gentle agitation. Cells were then separated
from the serum by centrifugation and the
latter tested immediately by MIF against
the appropriate target cells or stored at
-200C.
Indirect meembrane immunofluorescence (MIF)
Fluorescent conjugates. (a) Fluoreseein-
ated anti-mouse globulin ofhorse origin (Pro-
gressive Laboratories, Baltimore, Maryland,
U.S.A.). This reagent, which on immuno-
electrophoresis with mouse serum gave a
strong single IgG line, was used unabsorbed
and appropriately diluted (usually 1: 10-
1: 20) with PBS prior to use. Titration of
each batch of fluoresceinated conjugate was
necessary to eliminate non-specific staining of
trypsinized sarcoma cells and to minimize
direct staining of immunoglobulin-bearing
cells in lymphoid cell preparations, particu-
larly normal spleen, and of lymphoid cell
contaminants of tumour cell preparations.
(b) Fluoreseeinated anti-rat globulin ofrabbit
origin (Microbiological Associates, Bethesda,
Maryland). This antiserum was used at a
dilution of approximately 1: 20 following gel
filtration through Sephadex G-100 at 4°C in
PBS (pH 7 3), under which conditions no
non-specific staining was observed. Specifi-
cityfor ratIgG was demonstrated byimmuno-
electrophoresis.
MIF technique. The MIF test was per-
formed on washed cell suspensions of high
viability (> 80%) obtained by mechanical
dissociation or enzymatic digestion from
tumour transplants. Sera in this test system
Mwere used either neat or diluted and were
always decomplemented at 56°C for 30 min
before use. To ensure objectivity antisera
were coded prior to testing.
Freshly dissociated cell suspensions were
dispensed into tubes to give an initial cell
concentration of2 x 106-4 x 106 cells. The
cells wTere incubated with 0 1-0 2 ml of
control or test serum at 37°C for 20 min in a
shaking water bath. The cell suspensions
were then washed three times with PBS by
centrifugation at 80 g for 4 min. After each
wash the pellet was resuspended by gentle
agitation. The final cell pack was incubated
at 37°C for 15 min in a shaking water bath
with 0-2 ml fluoreseeinated anti-mouse or
anti-rat immunoglobin, and the washing pro-
cedure with PBS repeated a further 3 times.
The final pellet was taken up in 01 ml
50% (v/v) glycerol in saline and cells were
examined for membrane staining using a Wild
M-20 fluorescence microscope fitted with an
HBO 200 mercury vapour burner and the
following filters: heat-absorbing filter (KG1);
u.v.-fluorescence exciting filter UGI (twice)
and FITC; red-absorbing filter BG38 and a
colourless barrier filter GG 13c.
Individual cells were examined at a
magnification of 250 or 500 diameters. Cells
exhibiting degrees ofmembrane staining from
more than two isolated points on the cell
surface to complete ring reactions were scored
as positive. Diffuse intracellular fluorescence
was taken to indicate cell death and such cells
were not enumerated. In addition, care was
taken to exclude cells with adherent fluor-
escent debris which might mimic a positive
membrane reaction. In general, the degree
of membrane staining in control suspensions
of lymphoid cells fell within the range 15 to
300o and was always greater than that ob-
served with mesenchymal cells where the
proportion was within the range 5-15%.
For each serum, a minimum of 200 cells
was counted and the results of each test were
expressed by a fluorescence index (F.I.)
calculated thus:
00 cells unstained
by control serum
0 cells unstained
by test serum
Qo cells unstained by control serum
Bulk fluorescence data were examined statisti-
cally and an F.I. of 0 3 considered significant
at the 10O level.
RESULTS
Presence of shared cell-surface antigens on
MISV-FBJ induced sarcomata. Detection
by indirect membrane iimnunofluorescence
(MIF) with mouse antisera
Sera from mice which had received
irradiated isografts ofFBJ sarcomata were
consistently reactive in indirect MIF tests
with cells from the corresponding im-
munizing tumours or with different FBJ
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tumours. In a series of 5 tests antisera
pooled from inmmune mice gave F.I.s
between 0 37 and 0 50 (mean F.I.
0 43 ± 0.05). By contrast, sera from
mice immunized with a weakly immuno-
genic radiation-induced sarcoma (T 115)
were unreactive with FBJ target cells
(F.I. 0.02), the number of stained cells
being comparable to that obtained follow-
ing incubation with normal mouse serum
(Table I).
TABLE I. Reactivity of Sera from Mice
Inamunized with FBJ Sarcomata against
FBJ Tumour Target Cells by Indirect
Membrane Immunofluorescence (MIF)
Serum (lonotT
A ~~Target
Immunizing cells in
ttumotur Pre-tieatment MIF test
FBJ 1/2-3 4xIR grafts* FBJ 1/4
FBJ 3/4-5 4 x IR grafts* FBJ 3/6
FBJ 4/4-6 4 x IR grafts* FBJ 6/4
FBJ 6/2-3 4 x IR grafts* FBJ 6/4
FBJ 7/3-4 4 x IR grafts* FBJ 7/5
T 115/10-12 4xIR grafts* FBJ 7/5
FBJ 2/4 Post-excisiont FBJ 1/7
FBJ 3/8 Post-excisiont FBJ 2/9
FBJ 4/2 Post-excisiont FBJ 4/6
FBJ 6/6 Post-excisiont FBJ 5/7
FBJ 6/10 Post-excisiont FBJ 6/12
FBJ 7/10 Post-excisiont FBJ 7/9
T 115/12 Post-excisiont FBJ 7/11
FBJ 1/1 Tumour-bearer4 FBJ 2/3
FBJ 3/2 Tumour-bearerl FBJ 3/4
FBJ 4/2 Tumour-bearer4 FBJ 4/4
FBJ 5/2 Tumour-bearert FBJ 6/3
FBJ 6/1 Tumour-bearert FBJ 6/3
FBJ 7/3 Tumour-bearerl FBJ 7/5
FBJ 3/2 Tumour-bearer4 T 115/13
FBJ 6/l Tumour-bearer4 T 115/14
FBJ 7/:3 Tumour-bearer+ T 115/1:3
Fluor-
escence
in(lex
(FT)
0-37
0-45
0-40
0-50
0-41
0-02
0 44
0-39
0-28
0-46
0-41
0-44
0-07
0-18
0-54
010
0*11
0-46
0.34
0-02
0 03
0-02
* Mice receive(l 4 bilateral grafts of irra(liate(1
(15,000 racd) tumour and were bled 10 (lays after the
fourth immunization.
t Tumouis were completely excised 10-15 (lays
after unilateral s.c. implantation andl mice were ble(i
10 days after the operationl.
Mice bearing sarcomatouis nodutles were bled
betwelen 14 and 42 days after implantation, depend-
ing on the growth rate of each neoplasm, when their
tumour cliameters were between 10 aid(l 15 mm.
T 115 was a ra(liation-in(luce(i osteosarcoma
t-ansplanted in CBA(H) mice.
Sera from mice which had borne viable
subcutaneous grafts of FBJ tumours dis-
played comparable reactivity in MIF tests
with FBJ sarcoma cells. F.l. values in
the range 0 28-0 46 (mean F.I.
0 40 ± 0.07) were obtained in tests and
the value in one test was insignificant (F.I.
0.28). The serum of a mouse from which
an unrelated neoplasm (T 115) had been
excised was negative (F.I. 0.07).
Antibody reactive with the membrane
of FBJ sarcoma cells was also demon-
strable in the sera of FBJ tumour-bearing
mice, although less consistently than in the
sera of mice which had received irradiated
isografts or from which FBJ sarcomata
had been excised. In 6 tests, 3 sera gave
significant F.I. values (0 34, 0 46 and 0.54)
against FBJ target cells while the values
obtained with 3 other sera were insignifi-
cant (01]0, 011 and 0.18). The mean F.I.
overall for the sera oftumour-bearing mice
in this group was 0 29 ± 0 19. In a
control test, the three positive antisera
failed to stain cells from sarcoma T 115
(mean F.I. 0 02 + 001).
The cross-reactive nature of the cell-
surface antigens expressed by FBJ sarco-
mata was further investigated in a series of
experiments in which antisera pooled from
3 separate groups of mice (A, B and C)
which had received irradiated FBJ cells
were tested against transplants of 7
independently induced FBJ sarcomata.
In this series, 15/1 6 tests were positive
(F.I. > 0 3) and the mean Fl.. was
0 39 L 0 05 (Table II).
The specificity of these antigens for
FBJ sarcoma cells was further evaluated in
tests where the 3 antisera were tested
against unrelated tumours and normal
tissues. The former included 2 radiation-
induced sarcomata (T 38 and T 115) and
2 chemically-induced sarcomata (MCB-2
and MCB-3) in syngeneic CBA mice, all of
which possessed weak cell surface antigens
as determined by tumour rejection tests
(Moore and Wlilliams, 1972; and un-
published data). The latter comprised
normal CBA spleen cells and embryo
fibroblasts. Wtithoutexceptionthesetests
were negative; the mean F.I. overall was
0 05 - 003 and the maximum recorded
F.I., 0()12.D. B. JONES AND M. MOORE
TABLE II.-Reactivity of Pooled Antisera
from Mice Hyperimmunized with Ir-
radiated (15,000 rad) FBJ Tumours
against Various Transplanted FBJ
Sarcomata and Unrelated Normal and
Malignant Tissues
Target cells
and transplant
generation
number
FBJ 1/7-8
FBJ 2/9-12
FBJ 3/8-14
FBJ 4/3-7
FBJ 5/10
FBJ 6/9-15
FBJ 7/10-14
T 38/12
T 115/16
MCB-2/10
MCB-3/9
CBA(H) spleen
CBA(H)
embryonic
fibroblasts
Fluorescence indices (FI) with
Antiserum Antiserum Antiserum
A* B* Ct
0-47 0-32 NT
0-41 0-39 0-42
0-36 0-29 0-36
0-42 0-38 NT
NT NT 0- 45
NT 0-41 0-44
0-37 0-34 0-42
0-02 NT NT
NT 0-07 0-03
0-06 0-02 0-06
NT NT 0-04
NT NT 0-12
NT NT 0-03
* Antisera A and B were pooled from two inde-
pendent groups of mice receiving 4 i.p. injections of
2 x 106 FBJ sarcoma cells at intervals of 10 days.
t Antiserum C was pooled from a third group of
mice which received 5 i.p. injections of 2 x 106 FBJ
sarcoma cells at intervals of 10 days.
T 38 and T 115 were radiation-induced osteo-
sarcomata in CBA(H) mice; MCB-2 and MCB-3 were
chemically-induced sarcomata in CBA(H) and
Balb/c mice respectively.
NT = Not tested.
Type-specificity of antigens in MSV-
induced sarcomata and Gross (G) virus-
infected tissues. Characterization by in-
direct membrane immunofluorescence with
mouse antisera
The type-specificity of the cell-surface
antigens shared by FBJ sarcoma cells was
investigated by MIF in comparative
experiments using target cells derived
from G-positive and G-negative tissues
andfrom tissues known to express antigens
of FMR subgroup specificity.
In the first experiment, the results of
which are presented in Table III, hyper-
immune FBJ antiserum (A) was tested
against 3 Gross virus-induced leukaemias,
normal mouse spleen cells, 2 murine
sarcomata induced by radiation and a
chemical carcinogen respectively and a
spontaneously arising leukaemia trans-
TABLE III.-Presence of Common Cell
Surface Antigens on FBJ Sarcoma Cells
and Gross (C) Antigen Positive Tissues
Fluorescence
index
Target cells in MIF test (FI)*
FBJ 7/10 0-37
AKR-primary leukaemic spleen 0-33
AKR-primary leukaemic thymus 0-42
ASL-3/2 (rat lymphoma) 0-49
CBA(H) spleen 0-15
BALB/c spleen 0-06
T 38/17 CBA(H) osteosarcoma 0-02
(radiation-induced)
MCB-2/12 CBA(H) sarcoma
(chemically-induced)
AF (primary spontaneous leukaemia)
0-06
0-05
* Using hyperimmune FBJ antiserum (A). See
Table II footnote.
planted in A strain mice and previously
shownbycomplementfixation tobedevoid
ofwildtype orGantigen (JonesandMoore,
1974). Positive reactions were obtained
against all Gross virus infected tissues,
which consisted of spleen and thymus
from an AKR mouse with primary leu-
kaemia and cells originating from the third
generation transplant of a GLV-induced
AS rat lymphoma, F.I.s ranging from 0-33
to 0-49 (mean F.I. 0-40 ± 0-07). By
contrast, the antiserum did not react with
other target cells (mean F.I. 0-07 ± 0-05).
These experiments thus indicated that
GLV-induced rat and mouse lymphomata
possess antigens in common with FBJ
sarcomata.
Evidence wasobtainedthat cell-surface
antigens shared by FBJ sarcomata and
AKR lymphomata are not expressed by
cells transformed by MSV-H (Harvey).
In reciprocal specificity tests sera from
mice immunized with irradiated isografts
of FBJ sarcomata proven to be reactive
with FBJ tumour target cells and GLV-
induced rat lymphoma (ASL-2/4) failed to
stainMSV-Hcells (CH-2/4); whileserafrom
mice immunized with a tumour transplant
of an MSV-H induced sarcoma (CH3/3) or
oncogenic cell-free extracts derived from
MSV-H tumours, were reactive with
MSV-H cells (CH 3/6 and CH 2/4), with
F.I.s 0-46 and 0-37 but failed to react with
two FBJ sarcomata (FBJ 4/11 and FBJ
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2/12) aind a G-positive rat lymphoma
(ASL-2/4), the F.I. values being 0-09, 0-06
and 011 respectively (Table IV). Nega-
tive reactivity was also recorded against a
radiation-induced murine osteosarcoma
(T 115) F.I. 0-04.
TABLE IV. Absence of Common Cell
Surface Antigens on FBJ Sarcoma Cells
and Tumours Induced by MSV-Harvey
Serum (lonor
Immumiz- Target
ing cells
tumour/ in MIF
virtus Pretreatment test
FBJ 7/13 5xIR grafts FBJ 6/14
CH-2/4
ASL-2/4
CH 3/,3 2 x i.p. injections of CH 3/6
2 x 106 IR cells FBJ 4/11
ASL-2/4
Virus Single i.p. CH 2/4
extract injections 0-5 ml FBJ 2/12
(MSV-H) 10-1 (lilution of T 115/21
20% (w/v) tumour
homogenate
Fluor-
escence
index
(FI)
0-44
0-00
0:34
0 46
0 09
011
0:37
0-06
0-04
Prefix CH (denotes tumour induced in CBA mouse
by MSV-H (Harvey), and ASL transplanted lym-
phoma indhuced in AS rat by GLV.
Presence of cell-surface antigen in MSV-
FBJ sarcoma cells reactive with naturally
occurring murine antibody with Gross (G)
specificity
The type-specificity of FBJ sarcoma
cells was further analysed in a series of
MIF tests using antisera from aged ex-
breeding C57B1 female mice which were
demonstrated to contain naturally occur-
ring antibody with specificity for Gross
(G) antigen. Target cells from 4 trans-
planted FBJ sarcomata were reactive with
sera from mice aged more than one year
with F.I.s in the range 0-54 to 0-62 (mean
F.l. 0-59 ± 0.03). These indices were
generally greater than those obtained
against target cells with sera from mice
immunized with FBJ sarcomata where the
range was 0-41 to 0-50 (mean F.I.
0-44 0.04). Antibody reactive with
FBJ sarcoma cells could be detected in the
sera of younger female C57B1 mice but
with lower indices (F.I. 0-30, 0-38). The
C'57B1 antisera were also reactive with
1 9
AKR leukaemic spleen but totally un-
reactive with normal CBA spleen. These
data thus indicated that antibody present
in the sera of aged C57B1 mice recognizes
an antigen present on the surface of both
FBJ sarcoma and AKR leukaemia cells.
Demonstration of similar type-specific anti-
yens on MSV-FBJ induced sarcomata and
Gross (G) virus-induced neoplasms by
serum absorption and indirect membrane
immunofiuorescence
The type specificity of FBJ sarcomata
was corroborated in a series of absorption
experiments in which mouse and rat anti-
sera reactive with Gross (G) antigen-
positive cells were variously absorbed with
FBJ and AKR tissues and G antigen
negative tissues. In the first of these
mouse FBJ antisera were preincubated
withgradednumbers ofviable tumour cells
and control cell types, and tested against
FBJ sarcoma target cells for the presence
of residual antibody against cell-surface
antigens. The results of a typical experi-
ment are illustrated in Fig. 1. The F.I. of
1-
LL
unabsorlbed No. of cells per ml antiserum absorbed
antiserum
FIG. 1. Demonstration of shared antigenic
specificities of FBJ sarcoma cells and AKR
leukaemia cells by absorption of hyper-
immune FBJ mouse antiserum. Target
cells, FBJ 7/10. Cells used for prior
absorption of antiserum were derived from
FBJ 11/6 (0 0); AKR mouse leukaemia
2/7 (--*), MCB chemically-induced sar-
coma (0-0) and normal CBA(H) spleen
(]L-O). F.I.values falling within the
shaded area of the graph are not significant.
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the unabsorbed antiserum (B see foot-
note to Table II) against FBJ target cells
was 0 55 + 0 04. Pretreatment with
MCB sarcoma cells or normal spleen cells
marginally reduced the F.I. of the un-
absorbed antiserum at the highest con-
centration of cells (108/ml antiserum) but
the F.I. with FBJ cells remained signifi-
cant at 0 50 and 0 35 respectively. By
contrast, pretreatment of the same anti-
serum with FBJ sarcoma and AKR
leukaemia cells reduced the F.I.s of the
unabsorbed antiserum to 0 29 and 0 20,
i.e. below the significant value of 0 30 at
concentrations (1 07 cells/ml antiserum)
one logarithmic unit less than the MCB
sarcoma or normal spleen cells. These
tests thus confirmed earlier results
obtained using unabsorbed sera to corro-
borate the finding that AKR leukaemic
cells and FBJ sarcoma cells possess cell
surface antigens in common.
Essentially similar profiles were ob-
tained when antisera from aged exbreeding
C57B1 female mice were preabsorbed with
comparable cell types. Prior incubation
t
unabsorbed
antiserum
1X106 1xiO7 1X108
No. of cells per ml antiserum absorbed
FIGt. 2. Incomplete absorptioin by FBJ sar-
coma cells of rat hetero-antibodies against
Gross leukaemia virus (GLV) associated
antigens. Target cells, AKR G+ rat
lymphoma. Cells used for prior absorption
of heteroantiserum weie (lerived from FBJ
7/16 (O ); AKR rat lymphoma 3/7
(0 * 0); MC, chemically-induced rat
sarcoma ( O O) and P8, radiation-induced
rat sarcoma (A -,). F.I. values falling
within the shacted area of the graph are not
significant.
TABLE V.-Presence of Comrnon C(ell
Surface Antigens on FBJ Sarcoma Cells
and AKR Leukaemic Cells Reactive with
NYaturally Occurring Antibody in the
Serum ofAged Y C57B1 Mice
Serum donor
C57B1 >I year
FBJ-3 immune*
FBJ-4 immune*
C57B1 > 1 year
FBJ-6 immune*
C57B1 <1 year
C57B1 >1 year
FBJ-7 immune*
FBJ-4 immune*
C57B1 < I year
C57Bl > 1 year
C57BI < I year
C57B1 > 1 year
C57B1 <1 year
C57B1 > 1 yeai
Target cells
in MIF test
FBJ 3/6
FBJ 3/6
FBJ 4/9
FBJ 4/9
FBJ 6/7
FBJ 6/7
FBJ 6/7
FBJ 7/10
FBJ 7/10
FBJ 7/10
FBJ 7/10
AKR-LI spleen
AKR-LI spleen
CBA(H) spleen
CBA(H) spleen
Fluorescence
index
(FI)
0 54
0 45
0 44
0-60
0 50
0 30
0 559
0-41
0-41
0-:38
0-62
0 39
0-48
0 09
O 11
Sera were (derivedl from exbreeding C57B1 female
mice aged between 6 and 18 months.
AKR-Ll spleen dlenotes spleen cells from
leukaemic AKR motuse.
* Sera from mice immunized by irradliate(d
(15,000 radl) grafts of FBJ sarcoma.
with normal CBA spleen cells or radiation-
induced sarcoma cells only minimally
reduced the F.I. of the unabsorbed C57B1
antiserum against FBJ sarcoma target
cells at concentrations up to 5 x 107 cells/
ml serum. By contrast, AKR leukaemic
spleen cells and FBJ sarcoma cells at cell
concentrations of one logarithmic less (i.e.
5 x 106/ml antiserum) reduced the F.I. of
the unabsorbed serum to below the
significant value of 0 30.
The complete absorption by FJ3J
sarcoma cells and AKR leukaemia cells of
mouse antisera directed against antigens
of G specificity contrasted with results
obtained when rat antisera containing
antibodies to a spectrum of Gross virus-
associated antigens were absorbed with
GLV-rat lymphoma cells, FBJ murine
sarcoma cells and cells of unrelated neo-
plasms (a chemically induced rat sarcoma
MC, and a radiation induced rat fibro-
sarcoma, P8) (Fig. 2). The F.I. of the
unabsorbed GLV rat antiserum against the
target cells in this instance (GLV-induced
rat lymphoma) was 0 75. Preabsorption
LL.
x
'a
0
0
CLL
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withunrelatedneoplasmsat concentrations
upto 108cells/mlantiserumscarcelyaffected
the F.I. of the antiserum against lym-
phoma cells whereas preincubation with
lymphoma cells at this concentration
completely abolished the reaction (F.I.
0.0). The effect of pretreatment of the
rat antiserum with FBJ sarcoma cells at
108 cells/ml antiserum was however inter-
mediate between that of the unrelated
sarcoma cells and the rat lymphoma cells
and a significant F.I. of 0 39 was recorded.
Thus absorption by FBJ cells ofantibodies
against GLV-associated antigens in rat
heteroantisera were, under the conditions
of this investigation, incomplete.
I)ISCUSSION
Cells transformed by members of the
murine leukaemia-sarcoma virus complex
express a number of antigens, principally
residing at the cell surface which are
detectable by transplantation and sero-
logical techniques. These antigens fall
into two distinct categories: (a) the Gross
(G) or "w 'ild" type antigen found in
Passage A (Gross) virus-induced, and many
spontaneous leukaemias as well as in
normal tissues of high leukaemic strains
(Old, Boyse and Stockert, 1965; Aoki,
Boyse and Old, 1966). (b) The FMR
antigen present on leukaemias induced by
Friend, Moloney, or Rauscher viruses
(XVahren, 1963; Klein and Klein, 1964;
Old, Boyse and Stockert, 1964). Previous
studies undertaken with tumours induced
by MSV-FBJ have established that in
common with sarcomata induced by other
MSV isolates (Fefer, McCoy and Glynn,
1967; Law, Ting and Stanton, 1968;
Koldovsky, Turano and Fadda, 1969;
McCoy et al., 1972) these neoplasms are
immunogenic in syngeneic hosts (Jones
and Moore, 1973). The induction of cell-
mediated immunity is paralleled by the
concomitant appearance of antibodies to
virus type-specific antigens in the serum of
immune mice, and less consistently in the
serum of tumour-bearing mice (Jones and
Moore, 1974).
In this study cell surface antigens
expressed on cells transformed in vivo by
MSV-FBJ have been detected by MIF on
viable suspensions using antisera from
mice immunized by protocols which give
rise to transplantation resistance and the
appearance of complement fixing (CF)
antibodies in serum. The antigens were
common to all FBJ tumours in the series as
determined by cross-reactivity tests but
absent from normal adult host tissues of
the CBA(H) mouse strain, certain allo-
geneic tissues and murine sarcomata
induced by radiation or a chemical
carcinogen. There is no conclusive evi-
dence that antigens detected by MIF are
identical with those mediating tumour
rejection or those which evoke the appear-
ance of CF antibodies. The humoral
response to the antigens expressed on FBJ
cells is such that antibodies are induced
which are demonstrable by more than one
serological technique. Theircloselyparal-
lel reactivity in different tests implies the
existence of some overlapping specificities
but the presence of other non-identical
antibodies in these sera cannot be
excluded.
Partial characterization of the FBJ
virus-specified antigens has been possible
using sera from FBJ immune mice in tests
against Gross (G) positive and negative
tissues. Cells transformed by MSV-FBJ
evoke the production of antibodies which
react with G+ cells such as AKR leu-
kaemic thymus and spleen, and GLV-
induced rat lymphomata but not with cells
transformed by a member of the FMR
series, e.g. MSV-H, or with other G-
tissues. These findings by MIF corro-
borate earlier studies in which the G or
wild type specificity of FBJ sarcomata
was established by CF tests using sera
raised in mice by similar immunization
schedules (Jones and Moore, 1974).
Comparable reactivity by CF and MIF
was also observed for antisera derived
from aged exbreeding C57B1 female mice.
These sera have been shown by cyto-
toxicity and MIF to contain antibody
reactive only with antigens ofG specificityD. B. JONES AND M. MOORE
(Aoki et al., 1966). The antibody lacks
significant virus neutralizing capacity
which suggests that the target antigen is
cellular rather than virion in nature, a
conclusion confirmed by immunoelectron
microscopic studies (Aoki et al., 1970).
The CF antibody demonstrated in C57B1
antisera (Jones and Moore, 1974) may be
reactive with the exfoliated form of this
antigen. The consistent reactivity ofFBJ
sarcomata and AKR tissues with this
antibody indicates that these cells express
G cellular antigen in addition to virion
envelope antigen (VEA) present in virus-
infected tissues which evokes virus-
neutralizing antibody (Kelloff et al., 1969).
No qualitative distinction in antigens
expressed by AKR leukaemias and FBJ
sarcomata was revealed in this investiga-
tion. This was particularly apparentfrom
absorption studies where cells from both
tissue sources exhibited a comparable
ability to absorb antibody with G specifi-
city whether naturally occurring in aged
ex-breeding C57B1 mice or induced by
FBJ sarcomata in syngeneic CBA mice.
Inability to detect residual antibody re-
active with FBJ sarcoma cells in FBJ
antisera following absorption with AKR
leukaemia cells implied that there was no
antigenic specificity on FBJ sarcoma cells
which was not also present on GLV-
infected cells. Absorption by FBJ sar-
coma cells of rat antibodies to GLV-
induced lymphoma cells was, on the other
hand, incomplete. This was not un-
expected, since these heteroantisera con-
tain antibodies to a broader spectrum of
Gross virus-associatedantigensthan mouse
antisera (Herberman, 1972), some ofwhich
represent antigenic specificities (e.g. the
GlX alloantigen) hitherto undetected on
non-lymphoid cells (Stockert, Old and
Boyse, 1971). The absorption data do
not provide conclusive proof of absence of
" MSV-non-MLV " antigens on FBJ sar-
coma cells since MLV-FBJ determined
antigens may overshadow MSV-specific
components which may be present on
these cells. In analogous studies neither
Fefer et al. (1967) nor Chuat et al. (1969)
could positively identify " MSV-non-
MLV" antigens on cells transformed by
MSV-M and MSV-H respectively, and
more recently, lack of distinctive antigen
on cells transformed by MSV has been
demonstrated using an S + L (sarcoma
positive, leukaemia negative) isolate
selected from among semisolid agar
colonies of MSV-transformed Swiss/3T3
cells (Strouk et al., 1972).
Experience in the serological analysis
of cell surface antigens of neoplasms
induced by murine leukaemia virus
(Herberman, 1972) suggests that in the
MSV-FBJ system we are likely to be
dealing with a complex ofvirus-associated
antigens, comprising a number of cellular
and virion determinants, which may be
further analysed by the application of
more sensitive techniques such as immuno-
electron microscopy (Aoki, Stephenson
and Aaronson, 1973). Until the function
of each antigen has been determined, no
statement may be made about which, if
any, of the antigens detected by different
in vitro techniques mediates in vivo
tumour rejection. Neoplastic trans-
formation by oncogenic viruses appears to
be associated in general with the appear-
ance of several neoantigens. Thus,
tumours induced by mammary tumour
viruspossessesindividually specific, aswell
asvirus-specified commonantigens (Vaage,
1968; Morton, Goldman and Wood, 1969);
while in the SV40 system, several ap-
parently distinct antigens have been
defined including a specifictransplantation
antigen (Habel and Eddy, 1963), trans-
plantation and cell surface antigens cross-
reactive with embryonic or egg antigens
(Coggin, Ambrose and Anderson, 1970;
Baranska, Koldovsky and Koprowski,
1970), the S antigen detected by immuno-
fluorescence (Trevethia, Katz and Rapp,
1965) and a tumour-specific cell surface
antigen detected by the isotopic anti-
globulin technique (Ting and Herberman,
1971). Viral genetic material may be
responsible for the appearance of some of
these antigens while derepression may
account for others.
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